Boston Scientific to Acquire SoniVie Ltd

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.

Samsung Medison Acquires French Ultrasound AI Firm Sonio

September 4, 2024

Medical Devices

Samsung Medison (part of Samsung) has completed a $92.4 million acquisition of Paris-based ultrasound AI company Sonio, acquiring 100% of the firm's shares after approval from the French Ministry of the Economy and Finance. Sonio — founded in 2020 and maker of FDA-cleared Sonio Detect for real-time fetal ultrasound guidance — will continue developing cross-vendor products while its AI capabilities are integrated into Samsung’s ultrasound roadmap.

Medtronic to Acquire Scientia Vascular for $550 Million

March 10, 2026

Healthcare Services

Medtronic entered into a definitive agreement to acquire Scientia Vascular in a deal valued at $550 million, subject to customary adjustments and potential earn-out/milestone payments. The acquisition is expected to close in the first half of Medtronic’s fiscal 2027, pending regulatory approvals and other closing conditions.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition is expected to expand Boston Scientific’s electrophysiology and structural heart portfolios by adding the RF NRG and VersaCross transseptal platforms and related guidewires, sheaths, and dilators.

BioVie Acquires Biopharma Assets of NeurMedix

June 11, 2021

Pharmaceuticals

BioVie Inc. acquired the biopharmaceutical assets of privately held NeurMedix, including NE3107, an orally administered small-molecule inhibitor targeting neuroinflammation and insulin resistance. The deal paid NeurMedix shareholders newly issued BioVie shares and cash at closing, with additional contingent cash and equity payments tied to clinical and regulatory milestones; the acquisition expands BioVie's pipeline into neurodegenerative diseases and oncology.

Medtronic Acquires SonarMed

May 10, 2021

Medical Devices

Medtronic plc acquired SonarMed, a Purdue‑bred developer of the SonarMed airway monitoring system, in December 2020. The acquisition adds continuous acoustic airway monitoring technology for neonatal and pediatric ventilation to Medtronic's respiratory/medical surgical portfolio to help detect endotracheal tube obstruction and position in real time.